Correlation Between Evolus and Pacira BioSciences,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evolus and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolus and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evolus Inc and Pacira BioSciences,, you can compare the effects of market volatilities on Evolus and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolus with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolus and Pacira BioSciences,.

Diversification Opportunities for Evolus and Pacira BioSciences,

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Evolus and Pacira is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Evolus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolus Inc are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Evolus i.e., Evolus and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between Evolus and Pacira BioSciences,

Given the investment horizon of 90 days Evolus Inc is expected to generate 0.59 times more return on investment than Pacira BioSciences,. However, Evolus Inc is 1.7 times less risky than Pacira BioSciences,. It trades about 0.02 of its potential returns per unit of risk. Pacira BioSciences, is currently generating about -0.05 per unit of risk. If you would invest  1,263  in Evolus Inc on August 24, 2024 and sell it today you would earn a total of  41.00  from holding Evolus Inc or generate 3.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Evolus Inc  vs.  Pacira BioSciences,

 Performance 
       Timeline  
Evolus Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evolus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Pacira BioSciences, 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.

Evolus and Pacira BioSciences, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evolus and Pacira BioSciences,

The main advantage of trading using opposite Evolus and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolus position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.
The idea behind Evolus Inc and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
CEOs Directory
Screen CEOs from public companies around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges